Kidney Dosimetry in ¹⁷⁷Lu and ⁹⁰Y Peptide Receptor Radionuclide Therapy: Influence of Image Timing, Time-Activity Integration Method, and Risk Factors

Table 4

Characteristics of different dosimetric approaches concerning acquisition timing and interpolation method.

Investigator	Therapeutic nuclide	Acquisition timings	Interpolation method
Esser et al. [4], Sandström et al. [5], Larsson et al. [9]	^177Lu	1, 4, 7 d	MN
Hindorf et al. [25]	^90Y	Not fixed, up to 19–48 h, 2–4 acquisitions	Not reported for kidneys
Baechler et al. [17]	^90Y, ^177Lu, ^111In	0.5, 4 h, 1, 2 d	MN of last three points
Cremonesi et al. [3]	^90Y, ^177Lu	1, 4 h, 1, 2, 3 d	MN or BI
Garkavij et al. [7]	^177Lu	1 h, 1, 4, 7 d	TRexp